What is Acadia Pharmaceuticals's AOCI?

Acadia Pharmaceuticals (ACAD) reported AOCI of -$563K in Q1 2026.

How has Acadia Pharmaceuticals's AOCI changed year-over-year?

Acadia Pharmaceuticals's AOCI decreased by 228.8% year-over-year, from $437K to -$563K.

What is the long-term trend for Acadia Pharmaceuticals's AOCI?

Over 5 years (2020 to 2025), Acadia Pharmaceuticals's AOCI has grown at a 109.3% compound annual growth rate (CAGR), from $36K to $1.45M.

Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.

Acadia Pharmaceuticals ACAD AOCI

AOCI at other companies

BiogenBIIB

-$140.2M+19.7%

Neurocrine BiosciencesNBIX

$400K-95.6%

Catalyst PharmaceuticalCPRX

$8K+147%

PTC TherapeuticsPTCT

$8.47M+161%

BridgeBio PharmaBBIO

-$8K—

Arrowhead ResearchARWR

$742K-83.1%

Other financials

Income statement

See full

Revenue$268.1M+9.7%

Gross profit$243.3M+8.6%

Operating income-$4.6M-124%

Net income$3.6M-80.8%

EPS (diluted)$0.02-81.8%

Balance sheet

See full

Cash & equivalents$282.2M+29.6%

Total debt$50.8M-9.3%

Total equity$1.2B+63.1%

Total assets$1.6B+41.8%

Cash flow

See full

Operating cash flow$34.0M+67.2%

CapEx$5.2M—

Free cash flow$28.8M+41.6%

Valuation

See full

Market cap$3.87B+37.0%

Profitability

See full

Gross margin91.5%-0.6pp

Operating margin7.4%-16.2pp

Net margin34.3%+11.3pp

FCF margin18.9%—

Returns & leverage

See full

Return on equity37.3%+0.1pp

Debt / equity0×0.0×

Current ratio3.6×+0.7×

Where this comes from

Reported directly by Acadia Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Acadia Pharmaceuticals's aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Acadia Pharmaceuticals's AOCI?: Acadia Pharmaceuticals (ACAD) reported AOCI of -$563K in Q1 2026.
How has Acadia Pharmaceuticals's AOCI changed year-over-year?: Acadia Pharmaceuticals's AOCI decreased by 228.8% year-over-year, from $437K to -$563K.
What is the long-term trend for Acadia Pharmaceuticals's AOCI?: Over 5 years (2020 to 2025), Acadia Pharmaceuticals's AOCI has grown at a 109.3% compound annual growth rate (CAGR), from $36K to $1.45M.
What does AOCI mean?: Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.